Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021
by
, , , ,
Kechun Zhang
1,†, 
Xue Liang
2,†,
Karen Lau Wa Tam
2,†,
Joseph Kawuki
2
,
Paul Shing-fong Chan
2,
Siyu Chen
2,
Yuan Fang
3,
He Cao
1,
Xiaofeng Zhou
1,
Yaqi Chen
1,
Tian Hu
1,
Hongbiao Chen
1 and
Zixin Wang
2,* 1
Longhua District Center for Disease Control and Prevention, Shenzhen 518110, China
2
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
3
Department of Health and Physical Education, The Education University of Hong Kong, Hong Kong SAR, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Vaccines 2023, 11(1), 170; https://doi.org/10.3390/vaccines11010170
Submission received: 16 December 2022
/
Revised: 9 January 2023
/
Accepted: 10 January 2023
/
Published: 12 January 2023
(This article belongs to the Section Human Vaccines and Public Health)
Abstract
:China is considering to offer COVID-19 vaccination for children aged 6–35 months. This study investigated the changes in COVID-19 vaccine acceptability and associated factors among parents with children aged 6–35 months in 2020 and 2021. Two rounds of cross-sectional online surveys were conducted among adult factory workers in Shenzhen, China. A subset of 208 (first round) and 229 (second round) parents with at least one child aged 6–35 months was included in the study. Parental acceptability of COVID-19 vaccination increased significantly from 66.8% in the first round to 79.5% in the second round (p = 0.01). Positive attitudes, perceived subjective norm, and perceived behavioral control were associated with higher parental acceptability in both rounds of surveys (p values ranged from <0.001 to 0.003). A negative association of negative attitudes with parental acceptability was observed in the second round (p = 0.02). No significant associations of exposure to information related to COVID-19 vaccination on social media with parental acceptability was found in either round of survey. Expanding the existing COVID-19 vaccination programs to cover children aged 6–35 months is necessary in China. Future programs should focus on modifying perceptions among parents to promote COVID-19 vaccination for children in this age group.
1. Introduction
Coronavirus diseases 2019 (COVID-19) is one of the major challenges in the 21st century [1]. The ongoing pandemic has resulted in global health, economic, and social crises. As of 28 November 2022, there have been 637 million confirmed cases including 6.6 million deaths worldwide [2]. In addition, some countries (e.g., China) repeatedly applied strict measures (i.e., routine COVID-19 screening, social distancing, and even lockdown of the entire city), with significant and long-lasting individual, social, and economic consequences [1]. In the early phase of the COVID-19 pandemic, most cases were middle-aged and older people [3,4], but as the pandemic progressed, an increasing trend in children with COVID-19 infection was observed [4]. Younger children are especially vulnerable to COVID-19 [5]. Children aged 6–35 months accounted for 3.6% of all COVID-19 cases in the United States [6], 3.1% in German [7], and 2.2% in the United Kingdom [8]. The proportion of children aged 6–35 months hospitalized due to the Omicron variant was about five times higher than when the Delta variant was the dominant strain [9]. Such a proportion was also higher than that of children aged 5–11 and 12–17 years during the same period [10]. In children, younger age was positively associated with COVID-19 mortality [11]. Therefore, preventive methods are urgent to protect younger children from COVID-19.
COVID-19 vaccination is highly effective in preventing COVID-19 and its equality should be guaranteed in populations and communities at risk of infection [12,13,14]. Vaccine efficacy was also evaluated in children aged between six months and five years and similar robust neutralizing antibody titers were observed [15]. Compared to young adults, the vaccine immunogenicity was non-inferior in children aged between six months and five years [16]. In this group of children, most adverse effects reported were mild to moderate and serious side effects were rare [17,18]. In June 2022, the United States amended the Emergency Use Authorization to include children aged 6–35 months for COVID-19 vaccination [19]. As of 16 November 2022, 1.7 million children aged between six months and four years have received at least one dose of COVID-19 vaccine, representing 10% of this age group in the United States [20]. Since September 2022, Australia has offered the Moderna vaccine to children aged between six months and four years [21]. COVID-19 vaccine was also approved for children aged six months to five years in Canada in July 2022 [22] and for those aged 6–35 months in Hong Kong in August 2022 [23]. China approved two inactivated COVID-19 vaccines (Sinopharm and SinoVac-CoronaVac) for children aged 3–17 years in July and October 2021 [24], and is considering to offer COVID-19 vaccination to children aged 6–35 months.
Sufficient vaccination coverage is conditioned by the people’s acceptance of these vaccines. However, providing children with COVID-19 vaccination is challenging due to low parental acceptability, especially for those of younger age [25]. Studies about parental acceptability of COVID-19 vaccination for children aged 6–35 months are still limited [26,27]. One cross-sectional study conducted in the United States showed that only 40% of parents were willing to vaccinate their children aged between six months and four years against COVID-19 [26]. A similar level of COVID-19 vaccination acceptability was found among parents with children under 18 months in the United Kingdom [27]. Routine childhood vaccination, receiving the seasonal influenza vaccine, perceived severity of COVID-19 in children, vaccine safety, and effectiveness were associated with higher vaccine acceptability [26]. Common concerns, such as vaccine safety, effectiveness, and rapid vaccine development, were negatively associated with vaccine acceptability [27]. In China, most studies investigating parental vaccine acceptability for children focused on children aged 6–18 years [28,29,30,31,32,33,34,35,36,37,38,39,40,41]. Our previous work investigated the changes in parental COVID-19 vaccine hesitancy for children aged 3–17 years [41]. Since the recommendation and policy for COVID-19 vaccination are very different for children aged 3–17 years and those aged 6–35 months, we expect the level of parental acceptability and determinants would be different between parents of older and younger children. According to the principle of social marketing, health promotion should be tailored to the needs of the target population [42]. Therefore, it is necessary to evaluate the parental acceptability of COVID-19 vaccination for children aged 6–35 months. This study could address the knowledge gap and inform the design of interventions/programs promoting COVID-19 vaccination among children aged 6–35 months.
The objectives of this study included: (1) to investigate the changes in parental acceptability of COVID-19 vaccination for children aged 6–35 months in 2020 and 2021 among factory workers in Shenzhen, China, and (2) to investigate factors associated with parental acceptability of COVID-19 vaccination at each time point. In the first round of survey, COVID-19 vaccination was not yet available in China. In the second round of survey, COVID-19 vaccination was available for children aged three years or above but was not yet available for children under three years. We hypothesized that parental vaccine acceptability would increase over time, and associated factors would differ at these two-time points.
2. Materials and Methods
2.1. Study Design
Two rounds of cross-sectional online surveys were conducted to explore COVID-19 vaccine acceptability among adult factory workers in Shenzhen Municipality, China from 1 to 7 September 2020 and 26 to 31 October 2021, respectively [41,43,44]. The study sites, sampling, and data collection of the two rounds were the same [41,43,44]. Shenzhen Municipality is a major and special economic zone in China and most factories were built in Longhua district, with 1517 factories and over one million factory workers in 2020 [45]. COVID-19 vaccination was available for children aged 12–17 in July 2021 [41] and 3–11 years in October 2021 [24].
2.2. Participants and Data Collection
Full-time factory workers aged 18 years or above in Shenzhen Municipality were recruited in the two rounds of surveys. We extracted data of participants having children aged 6–35 months for this study. Details of data collection have been described previously [41,43,44]. Factory workers in Shenzhen are required to receive physical examination every 12 months. Such physical examination is required to renew their working permit/contract. All organizations in Longhua District providing annual physical examination to factory workers, including three public hospitals, two private hospitals, and the CDC, were selected for recruitment of participants in both rounds. Fieldworkers approached all workers attending the sites for physical examination during the study period and obtained informed consent from potential participants. Since the interval between the first and second round was 14 months, most factory workers who participated in the first round should have completed the physical examination before the start of the second round. Therefore, our participants were likely to comprise two random samples derived from about one million factory workers. The chance of having the same participant completing both surveys was very low and not of practical concern.
A common encrypted online survey platform, Questionnaire Star, was used to collect information. Quick response (QR) codes were provided to access the online questionnaire and each mobile device was only allowed once for the questionnaire response to avoid duplication. The survey included about 20 items and took around 20 min to complete. A completeness check was performed before participants submitted their questionnaires. An e-coupon with 10 RMB (1.5 USD) was sent to participants once completion. All data was stored on the online survey platform server, and only the corresponding author had access to the database. Longhua District CDC provided the ethics approval (references 2020001 and 2021015).
2.3. Measures
2.3.1. Design of the Questionnaire
A panel, including one member of CDC staff, two public health researchers, a health psychologist, and a factory worker, developed the questionnaire. A pilot test was conducted to assess the clarity and readability among 10 factory workers, who did not participate in the actual survey. The questionnaire was revised and finalized based on the workers’ comments.
2.3.2. Background Characteristics
Demographic information, including age, sex, relationship status, education, monthly personal income, type of work, and age of the child were collected. Compliance with personal preventive behaviors was estimated using validated tools [46,47,48], including frequency of face mask wearing when having close contact with others in the workplace and other public spaces and hand sanitizing after returning from public spaces or touching public installations (every time, often, sometimes and never). Self-reported avoiding of social and meal gathering with people who did not live together and in crowded places in the last month was also measured.
2.3.3. COVID-19 Vaccine Acceptability for Their Children
Vaccine acceptability in both rounds of surveys was assessed by asking, “What is your likelihood of having your child take up free COVID-19 vaccination provided by the government?” (Response categories: 1 = very unlikely, 2 = unlikely, 3 = neutral, 4 = likely and 5 = very likely). Parental acceptability was defined as “very likely” or “likely” in both rounds. The same definition of parental acceptability was used in other published studies [29,49].
2.3.4. Individual Level Factors: Parental Hesitancy to Receive a COVID-19 Vaccination and Attitudes toward COVID-19 Vaccination for Their Children
In both rounds, parents who had not received COVID-19 vaccination were asked about their likelihood to take up such vaccination in future (response categories: 1 = very unlikely, 2 = unlikely, 3 = neutral, 4 = likely and 5 = very likely). Unvaccinated parents who were very unlikely/unlikely/neutral to take up COVID-19 vaccination future were defined as having parental vaccine hesitancy.
Items/scales on attitudes toward COVID-19 vaccination were constructed in our previous study, which was one of the first studies looking at parental attitudes toward COVID-19 vaccination. Since there was no validated questionnaires on this topic in early 2020, the items and scales were self-constructed based on those from previous studies on parental acceptability of human papillomavirus vaccination in China [50]. Positive and negative attitudes toward COVID-19 vaccination were measured by two scales. The Cronbach’s alpha of these two scales in the original study was 0.71 and 0.64, respectively. The internal reliability was acceptable. In the original study, we conducted exploratory factor analysis for these two scales. The scales had single factors explaining 64.0% and 56.6% of the total variance (Supplementary Materials). Perceived subjective norm and perceived behavioral control were assessed by asking “Your family member would support you in having your child take up COVID-19 vaccination” and “Having the child receive COVID-19 vaccination is easy for you if you want them to”, respectively. Disagree, neural and agree were rated for each item.
2.3.5. Interpersonal Level Factors: Influence of Social Media
In both rounds, participants were asked about the frequency of exposure to experiences related to COVID-19 vaccination on social media (such as WeChat and Weibo), shared by recipients in the last month. In the second round, four other types of information on social media were collected, including (1) the COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination, (2) infectiousness and harms of the variants concern of COVID-19, (3) outbreak caused by variants concern of COVID-19 in some places of China, and (4) people contract COVID-19 after receiving primary series of COVID-19 vaccines. Each item was rated from 1 = almost never, 2 = seldom, 3 = sometimes, to 4 = always.
2.4. Sample Size Planning
The original study had two rounds of cross-sectional online surveys looking at COVID-19 vaccination uptake and attitudes among adult factory workers in Shenzhen, China. The target sample size was 2000 for the original study in both rounds, which has been explained in previous papers [43,44]. This study was based on a sub-sample of these participants who had at least one child aged 6–35 months. Our reference population was factory workers having children aged 6–35 months in Shenzhen, China. Assuming that approximately 10% of the participants had a child aged 6–35 months (n = 200), we estimated about 60–70% of parents showed vaccine acceptability for their children in the first round. The smallest between-round difference in vaccine acceptability of 9.9% could be detected (power = 0.80, alpha = 0.05; PASS 11.0, NCSS, LLC, Kaysville, UT, USA).
2.5. Statistical Analyses
Differences in background characteristics, parental acceptability, attitudes toward COVID-19 vaccination and social media influence between participants in the first and second round of survey were compared using Chi-square tests (for categorical variables) or independent-sample t-tests (for continuous variables). Unadjusted p values were obtained. Using parental acceptability, attitudes toward COVID-19 vaccination, and social media influence as dependent variables, round of survey as independent variable (second versus first), and adjusting for significant background characteristics with between-group differences, adjusted p values were obtained by logistic regression models (for binary dependent variables) or linear regression models (for continuous dependent variables). Regarding the effect sizes of the between-round comparisons, Cohen’s d was calculated for continuous variables and Cohen’s h was calculated for proportions. For parents in the same round of the survey, Logistic regression models were used to assess the association of vaccine acceptability with background characteristics, attitudes toward COVID-19 vaccination, and influence of social media, giving odds ratio (ORs) and 95% confidence interval (CI). Statistical analyses were conducted using R software (version 4.1.2, ST Louis, MO, USA). All tests were two-sided with p < 0.05 as statistically significant.
3. Results
3.1. Background Characteristics of the Participants
A total of 2653 and 3060 eligible factory workers were approached in the first and second rounds of surveys, 600 and 434 refused to join the study due to a lack of time or other logistical reasons, and 2053 and 2626 completed the surveys with the response rate being 77.3% and 85.8%, respectively. Among these participants, 208 and 229 with at least one child aged 6–35 months were included in the analyses.
Table 1 showed that the mean age of parents was 30.9 and 33.1 years in the first and second round, respectively. The majority of them were female (first round: 57.2%, second round: 57.2%), married (first round: 97.6%, second round: 97.8%), with monthly personal income between 3000 and 6999 RMB (first round: 53.8%, second round: 60.7%), working as frontline workers (first round: 63.5%, second round: 69.9%), and with children aged 24–35 months (first round: 53.8%, second round: 52.0%). As compared with parents in the first round, those in the second round were older (p < 0.001) and had higher education levels (p = 0.02).
3.2. Changes in Parental Acceptability and Attitudes toward Children’s COVID-19 Vaccination
Parental acceptability of COVID-19 vaccination increased significantly from 66.8% in the first round to 79.5% in the second round (p = 0.01). Significant increases were also found in positive attitudes, negative attitudes, perceived subjective norm, and perceived behavioral control related to children’s COVID-19 vaccination (p values ranged from <0.001 to 0.04). More parents in the second round were exposed to testimonials given by recipients of COVID-19 vaccination on social media compared to those in the first round (p < 0.001) (Table 2).
3.3. Factors Associated with Parental Acceptability of COVID-19 Vaccination
In the first round, better compliance with physical distancing behaviors was associated with higher parental acceptability. In the second round, being female, and having better compliance in terms of face mask wearing in the workplace and hand hygiene were associated with higher parental acceptability. Higher education level was negatively associated with parental acceptability (Table 3).
After adjusting for the above significant background characteristics, positive attitudes (adjusted odds ratio (AOR): 1.86 and 1.99, p < 0.001), perceived subjective norm (AOR: 4.69 and 8.33, p < 0.001), and perceived behavioral control (AOR: 2.02 and 3.09, p = 0.003 and <0.001) were associated with higher parental acceptability for children in the first and second rounds, respectively. Parental hesitancy to receive COVID-19 vaccination was negatively associated with vaccine acceptability for children in the first round (AOR: 0.25, p < 0.001). In the second round, negative attitude was associated with lower parental acceptability (AOR: 0.80, p = 0.02). The association between frequency of information exposure on social media and the dependent variable was not statistically significant in either round (Table 4). Regarding the associations between individual items of the Positive/Negative Attitude Scale and the dependent variable, belief that COVID-19 vaccination is highly effective in protecting your child from COVID-19 was associated with higher parental acceptability in both rounds of surveys. Perceive adequate supply of COVID-19 vaccines was associated with higher parental acceptability in the first round of surveys, but not in the second (Appendix A).
4. Discussion
To our knowledge, this was the first study to monitor the changes in COVID-19 vaccine acceptability among parents with children aged 6–35 months. Factors at both individual and interpersonal levels were considered, which provided a more comprehensive understanding about the determinants of parental acceptability. The findings enriched international literature about parental acceptability of COVID-19 vaccination for children under the age of three years. The findings also had some practical implications to inform development of vaccination programs and related health promotion for this group of children. Currently, the risk of COVID-19 infection under the age of three years increased dramatically after the country changed its zero COVID policy. It was expected that the fear about COVID-19 and its consequences would be a major stressor for parents of young children [1]. Rolling out a vaccination program for young children is the first method to mitigate the impacts of pandemic on parents.
Parental acceptability of COVID-19 vaccination for children increased from 66.8% in the first round to 79.5% in the second round, possibly due to the increasing coverage of COVID-19 vaccination in adults. Most parents had already received the vaccine when the second round of survey was conducted. As of 3 December 2022, 90.7% of the entire population in China had received primary series of COVID-19 vaccine [51]. In addition, the recommendation of COVID-19 vaccine for children aged 3–17 years [52] may be another reason for the increased acceptability. The coverage of COVID-19 vaccination among children in China has been increasing rapidly without serious safety concerns [53]. The levels of parental acceptability in both rounds were higher than that reported in the United States (39.7%) [26] and the United Kingdom (48.2%) [27]. However, such levels of parental acceptability among our participants were lower when compared to Chinese parents having older children [31,33,34,37,38,40,49]. Younger age of the children and the availability of vaccines might be reasons to explain such differences. As compared to other jurisdictions (i.e., United States, Australia, Canada, and Hong Kong SAR of China) [21,22,23], mainland China was late in rolling out COVID-19 vaccination for children aged below three years. China may learn from the experience and evidence of these jurisdictions and expand the existing vaccination programs to children aged 6–35 months. This is especially important for protecting these young children after the country decided to change its zero COVID policy.
Compared to the first round, significant increases were observed in attitudes favoring COVID-19 vaccination for children, including positive attitudes, perceived subjective norm, and perceived behavioral control in the second round. The health promotion conducted by governments, availability of COVID-19 vaccine for children aged 3–17 years, and associated vaccination experiences from older children may explain the observed changes. Positive attitudes were associated with higher parental COVID-19 vaccine acceptability for children, which was consistent with previous studies [27,29,31,33,41]. When promoting COVID-19 vaccination for children aged 6–35 months, health communication messages emphasizing importance of childhood vaccination in overall pandemic control and sufficient supply of the vaccines should be disseminated to parents. In addition, studies should obtain more data about the efficacy of inactivated COVID-19 vaccines among young children, as such information is also useful in increasing parents’ positive attitudes toward the vaccines. However, negative attitudes also increased over time, with a higher proportion of parents concerned about the short duration of protection and time constraints to take their children for COVID-19 vaccination. The COVID-19 booster dose was unavailable for children in China, which may partly explain the concern of protection duration. A booster dose was shown to be effective in a long-time vaccine efficacy trial in children aged 5–15 years from the United States [54]. Kindergarten-based COVID-19 vaccine programs may partly solve the time concern among working parents. Such an approach can also increase perceived behavioral control related to children’s COVID-19 vaccination among parents, which was a significant determinant in both rounds of surveys. Moreover, perceived support regarding children’s vaccination increased over time and was associated with higher parental acceptability at both rounds. Future programs promoting COVID-19 vaccination among young children should encourage parents to communicate with other family members to obtain more support from these significant others.
Some non-significant findings also provided insights for planning future interventions. In contrast to our hypothesis, exposure to information related to COVID-19 vaccination on social media was not a significant determinant of parental acceptability in either round of survey. Therefore, future programs promoting COVID-19 vaccination among children aged 6–35 months should focus on modifying perceptions among parents.
Our study had several limitations. First, our findings are most applicable to the time when zero COVID policy was implemented in China. When China started to relieve its strict COVID-19 control measures in December 2022, the number of new cases increased dramatically. Parents may perceive a much stronger need to vaccinate their children against COVID-19. Second, participants referred to the child whose birthday was closest to the survey date when answering questions related to parental acceptability if they had more than one child under the age of 18 years. Therefore, we did not collect information about their other children’s COVID-19 vaccination status. Other children’s vaccination status may represent an important determinant of parental acceptability for their younger children. Third, the history of COVID-19 infection was not collected in our surveys, and an Italian study showed that parents with children previously experiencing COVID-19 were more likely to support the vaccination [55]. However, as the daily confirmed cases were very low during the two surveys due to the zero COVID policy in China, the COVID-19 infection history would not substantially influence the results. Fourth, we did not ask participants in the second round whether they attended the first round of survey. In Shenzhen, factory workers are required to receive physical examination every 12 months to renew their working permit/contract. The interval between the first and second round of survey was 14 months. The chance of a participant completing both rounds of surveys was very low. Fifth, the second round did not measure awareness of childhood COVID-19 vaccination. However, the awareness should be high among parents, as in the past two years, COVID-19 vaccination for children has been strongly promoted via various social media in China. Sixth, all participants were factory workers. Failure to include parents with other occupations or those without full-time work was one major limitation of this study and limited the representativeness of our sample. All participants were recruited in Shenzhen Municipality, one of the first-batch cities for COVID-19 vaccination in China which may have higher parental vaccine acceptability than less developed regions. Generalization of the results should be taken with caution when applying the findings to other cities. Moreover, selection bias existed due to non-response. Characteristics between participants and refusals could not be compared as no information was collected from refusals. Nonetheless, our response rate in both rounds was higher than in studies with similar topics [29,30,31,34,37,38,40,41,49]. Last but not least, the study was cross-sectional and so it could not establish causal relationships.
5. Conclusions
This study compared parental COVID-19 vaccination acceptability for children aged 6–35 months in 2020 and 2021 among factory workers in Shenzhen, which is one of four most developed cities in China. The prevalence of parental acceptability was relatively high and had been increasing over time. Expanding the existing COVID-19 vaccination programs to cover this age group of young children is necessary in China. Future programs promoting COVID-19 vaccination for children in this age group should focus on modifying perceptions among parents, such as increasing positive attitudes, perceived subjective and perceived behavioral control, and reducing negative attitudes related to children’s vaccination.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines11010170/s1, Material S1: Questionnaires used in the first and second round surveys.
Author Contributions
Conceptualization, K.Z., X.L., K.L.W.T. and Z.W., methodology, K.Z., X.L., K.L.W.T. and Z.W.; data curation, K.Z., H.C. (He Cao), X.Z., Y.C., T.H. and H.C. (Hongbiao Chen); formal analysis, K.Z., Y.F. and Z.W.; project administration, K.Z., H.C. (He Cao), X.Z., Y.C., T.H. and H.C. (Hongbiao Chen); supervision, K.Z. and Z.W.; writing—original draft preparation, X.L., K.L.W.T., J.K., P.S.-f.C., S.C., Y.F. and Z.W.; writing—review and editing, X.L., J.K., P.S.-f.C., S.C., Y.F. and Z.W. All authors have read and agreed to the published version of the manuscript.
Funding
The research was funded by the High-Level Project of Medicine in Longhua, Shenzhen (HLPM20190702105), and the Key Discipline of Infectious Diseases Control and Prevention of Long Hua (grant number 2020–2014).
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Longhua District CDC (reference: 2020002 and 2021015).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The data presented in this study are available from the corresponding author upon request. The data are not publicly available as they contain personal behaviours.
Acknowledgments
The authors would like to express their gratitude to all subjects for their engagement in this study.
Conflicts of Interest
The authors declare no conflict of interest.
Appendix A. Associations between Individual Items of the Positive/Negative Attitude Scale and Parental Acceptability
| Round 1 (n = 208) | Round 2 (n = 229) | |||||||
|---|---|---|---|---|---|---|---|---|
| OR (95%CI) | p Values | AOR (95%CI) | p Values | OR (95%CI) | p Values | AOR (95%CI) | p Values | |
| Positive Attitudes Scale | ||||||||
| COVID-19 vaccination is highly effective in protecting your child from COVID-19 | 6.75 (3.54, 12.86) | <0.001 | 6.72 (3.48, 12.96) | <0.001 | 7.68 (3.81, 15.50) | <0.001 | 8.14 (3.98, 16.66) | <0.001 |
| Taking up COVID-19 vaccination can contribute to the control of COVID-19 in China | 2.27 (1.02, 5.09) | 0.04 | 2.08 (0.92, 4.75) | 0.08 | 2.81 (0.95, 8.35) | 0.06 | 2.91 (0.97, 8.72) | 0.06 |
| China will have an adequate supply of COVID-19 vaccine | 1.90 (0.98, 3.70) | 0.06 | 2.07 (1.03, 4.14) | 0.04 | 1.59 (0.62, 4.08) | 0.33 | 1.66 (0.64, 4.29) | 0.30 |
| Negative Attitudes Scale | ||||||||
| Your child will have severe side effects after receiving COVID-19 vaccination | 0.99 (0.42, 2.34) | 0.99 | 1.02 (0.42, 2.45) | 0.97 | 0.64 (0.28, 1.49) | 0.30 | 0.61 (0.26, 1.44) | 0.26 |
| The protection of COVID-19 vaccines will only last for a short time | 1.29 (0.63, 2.65) | 0.49 | 1.39 (0.66, 2.92) | 0.38 | 0.76 (0.40, 1.44) | 0.40 | 0.76 (0.40, 1.46) | 0.41 |
| Your child is afraid of vaccination | 0.91 (0.47, 1.80) | 0.80 | 0.97 (0.49, 1.95) | 0.94 | 1.43 (0.64, 3.18) | 0.38 | 1.45 (0.65, 3.25) | 0.36 |
| You do not have time to take your child for COVID-19 vaccination | 1.67 (0.71, 3.93) | 0.24 | 1.79 (0.75, 4.29) | 0.19 | 1.80 (0.78, 4.11) | 0.17 | 1.79 (0.78, 4.11) | 0.17 |
References
- Barchielli, B.; Cricenti, C.; Gallè, F.; Sabella, E.A.; Liguori, F.; Da Molin, G.; Liguori, G.; Orsi, G.B.; Giannini, A.M.; Ferracuti, S.; et al. Climate Changes, Natural Resources Depletion, COVID-19 Pandemic, and Russian-Ukrainian War: What Is the Impact on Habits Change and Mental Health? Int. J. Environ. Res. Public Health 2022, 19, 11929. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization (WHO). Coronavirus COVID-19 Dashboard. Available online: https://covid19.who.int (accessed on 8 December 2022).
- Mueller, A.L.; McNamara, M.; Sinclair, D. Why does COVID-19 disproportionately affect older people? Aging 2020, 12, 9959–9981. [Google Scholar] [CrossRef]
- Cui, X.; Zhao, Z.; Zhang, T.; Guo, W.; Guo, W.; Zheng, J.; Zhang, J.; Dong, C.; Na, R.; Zheng, L.; et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J. Med. Virol. 2020, 93, 1057–1069. [Google Scholar] [CrossRef] [PubMed]
- Clarke, K.; Kim, Y.; Jones, J.; Lee, A.; Deng, Y.; Nycz, E.; Hall, A.J. Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Estimation Using Commercial Laboratory Specimens: How Representative Is It of the General U.S. Pediatric Population? 2022. Available online: https://ssrn.com/abstract=4092074 (accessed on 27 November 2022).
- Centers for Disease Control and Prevention: COVID Data Tracker—Wastewater Suveillance (2021). Available online: https://covid.cdc.gov/covid-data-tracker/#wastewdatatracker-home (accessed on 11 April 2022).
- Statista. Number of Coronavirus (COVID-19) Cases in Germany in 2022, by Age Group and Gender. 2022. Available online: https://www.statista.com/statistics/1105465/coronavirus-covid-19-cases-age-group-germany/ (accessed on 28 November 2022).
- GOV.UK. Coronavirus (COVID-19) in the UK. 2022. Available online: https://coronavirus.data.gov.uk/details/cases?areaType=nation&areaName=England (accessed on 28 November 2022).
- Marks, K.J.; Whitaker, M.; Agathis, N.T.; Anglin, O.; Milucky, J.; Patel, K.; Pham, H.; Kirley, P.D.; Kawasaki, B.; Meek, J.; et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, March 2020–February 2022. MMWR Morb. Mortal Wkly. Rep. 2022, 71, 429–436. [Google Scholar] [CrossRef] [PubMed]
- COVID-19 Epidemiology in Children Ages 6 Months–4 Years. 2022. Available online: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-06-17-18/02-covid-fleming-dutra-508.pdf (accessed on 29 November 2022).
- Gonzalez-Dambrauskas, S.; Vasquez-Hoyos, P.; Camporesi, A.; Cantillano, E.M.; Dallefeld, S.; Dominguez-Rojas, J.; Francoeur, C.; Gurbanov, A.; Mazzillo-Vega, L.; Shein, S.L.; et al. Paediatric critical COVID-19 and mortality in a multinational prospective cohort. Lancet Reg. Health Am. 2022, 12, 100272. [Google Scholar] [CrossRef]
- Tregoning, J.S.; Flight, K.E.; Higham, S.L.; Wang, Z.; Pierce, B.F. Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 2021, 21, 626–636. [Google Scholar] [CrossRef]
- Bolcato, M.; Rodriguez, D.; Feola, A.; Di Mizio, G.; Bonsignore, A.; Ciliberti, R.; Tettamanti, C.; Aurilio, M.T.; Aprile, A. COVID-19 Pandemic and Equal Access to Vaccines. Vaccines 2021, 9, 538. [Google Scholar] [CrossRef]
- Aurilio, M.T.; Mennini, F.; Gazzillo, S.; Massini, L.; Bolcato, M.; Feola, A.; Ferrari, C.; Coppeta, L. Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic. Vaccines 2021, 9, 500. [Google Scholar] [CrossRef]
- Fox, J.; White, P.J.; Macdonald, N.; Weber, J.; McClure, M.; Fidler, S.; Ward, H. Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: A cohort of high-risk men who have sex with men. HIV Med. 2009, 10, 432–438. [Google Scholar] [CrossRef]
- Colfax, G.N.; Buchbinder, S.P.; Cornelisse, P.G.A.; Vittinghoff, E.; Mayer, K.; Celum, C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. Aids 2002, 16, 1529–1535. [Google Scholar] [CrossRef]
- Hause, A.M.; Marquez, P.; Zhang, B.; Myers, T.R.; Gee, J.; Su, J.R.; Parker, C.; Thompson, D.; Panchanathan, S.S.; Shimabukuro, T.T.; et al. COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years—United States, 18 June 2022–21 August 2022. MMWR Morb. Mortal Wkly. Rep. 2022, 71, 1115–1120. [Google Scholar] [CrossRef] [PubMed]
- Ghanem, A.; Little, S.J.; Drumright, L.; Liu, L.; Morris, S.; Garfein, R.S. High-Risk Behaviors Associated with Injection Drug Use Among Recently HIV-Infected Men Who Have Sex with Men in San Diego, CA. AIDS Behav. 2011, 15, 1561–1569. [Google Scholar] [CrossRef]
- Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization Reissued 8 July 2022; US Department of Health and Human Services, Food and Drug Administration: Silver Spring, MD, USA, 2022; Available online: https://www.fda.gov/media/150386/download (accessed on 27 November 2022).
- Summary of Data Publicly Reported by the Centers for Disease Control and Prevention. 2022. Available online: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-vaccination-trends/ (accessed on 27 November 2022).
- Australian Government. ATAGI recommend the COVID-19 Vaccination for Some Children Aged 6 Months to under 5 Years. Available online: https://www.health.gov.au/news/atagi-recommend-the-covid-19-vaccination-for-some-children-aged-6-months-to-under-5-years (accessed on 3 January 2023).
- National Advisory Committee on Immunization (NACI). Recommendations on the Use of Moderna Spikevax COVID-19 Vaccine in Children 6 Months to 5 Years of Age. Available online: https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years.pdf (accessed on 3 January 2023).
- The Government of the Hong Kong SAR. COVID-19 Vaccination of Children Aged under 3 Begins Today. Available online: https://www.info.gov.hk/gia/general/202208/04/P2022080400470.htm (accessed on 3 January 2023).
- Shenzhen Municipal Health Commission. Frequent Answers and Questions about the Implementation of COVID-19 Vaccines for Children Aged 3–11 Years Old in 2021. Available online: http://wjw.sz.gov.cn/yqxx/content/post_9299120.html (accessed on 1 August 2022).
- She, J.; Liu, L.; Liu, W. Providing children with COVID-19 vaccinations is challenging due to lack of data and wide-ranging parental acceptance. Acta Paediatr. 2021, 111, 35–44. [Google Scholar] [CrossRef] [PubMed]
- Mangat, C.; Rich, J.; Sanghavi, D.; Schmidt, R.; Milosavljevic, N.; Linh, T.; Bansal, P. Parents’ perspective on COVID-19 vaccine in children 6 months through 4 years: A cross-sectional study from Northwest Wisconsin. BMJ Open 2022, 12, e065453. [Google Scholar] [CrossRef]
- Bell, S.; Clarke, R.; Mounier-Jack, S.; Walker, J.L.; Paterson, P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2020, 38, 7789–7798. [Google Scholar] [CrossRef]
- Wang, Q.; Xiu, S.; Zhao, S.; Wang, J.; Han, Y.; Dong, S.; Huang, J.; Cui, T.; Yang, L.; Shi, N.; et al. Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional Study. Vaccines 2021, 9, 342. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; She, R.; Chen, X.; Li, L.; Li, L.; Huang, Z.; Lau, J.T.F. Parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese doctors and nurses: A cross-sectional online survey. Hum. Vaccines Immunother. 2021, 17, 3322–3332. [Google Scholar] [CrossRef]
- Xu, Y.; Zhang, R.; Zhou, Z.; Fan, J.; Liang, J.; Cai, L.; Peng, L.; Ren, F.; Lin, W. Parental psychological distress and attitudes towards COVID-19 vaccination: A cross-sectional survey in Shenzhen, China. J. Affect. Disord. 2021, 292, 552–558. [Google Scholar] [CrossRef]
- Feng, H.; Zhu, H.; Zhang, H.; Cao, L.; Li, L.; Wang, J.; Huang, Y.; Lai, X.; Lyu, Y.; Jing, R.; et al. Caregivers’ intentions to COVID-19 vaccination for their children in China: A cross-sectional survey. Hum. Vaccines Immunother. 2021, 17, 4799–4805. [Google Scholar] [CrossRef]
- Du, M.; Tao, L.; Liu, J. The Association Between Risk Perception and COVID-19 Vaccine Hesitancy for Children Among Reproductive Women in China: An Online Survey. Front. Med. 2021, 8, 1494. [Google Scholar] [CrossRef]
- Wan, X.; Huang, H.; Shang, J.; Xie, Z.; Jia, R.; Lu, G.; Chen, C. Willingness and influential factors of parents of 3-6-year-old children to vaccinate their children with the COVID-19 vaccine in China. Hum. Vaccines Immunother. 2021, 17, 3969–3974. [Google Scholar] [CrossRef] [PubMed]
- Wu, L.; Huang, Z.; Guo, X.; Liu, J.; Sun, X. Measuring parents’ acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China. Hum. Vaccines Immunother. 2022, 18, 2069427. [Google Scholar] [CrossRef] [PubMed]
- Zhang, M.X.; Lin, X.Q.; Chen, Y.; Tung, T.H.; Zhu, J.S. Determinants of parental hesitancy to vaccinate their children against COVID-19 in China. Expert Rev. Vaccines 2021, 20, 1339–1349. [Google Scholar] [CrossRef] [PubMed]
- Xu, Y.; Xu, D.; Luo, L.; Ma, F.; Wang, P.; Li, H.; Li, Q.; Wei, L.; Diao, J.; Liu, Y.; et al. A Cross-Sectional Survey on COVID-19 Vaccine Hesitancy Among Parents from Shandong vs. Zhejiang. Front. Public Health 2021, 9, 1722. [Google Scholar] [CrossRef]
- Wu, J.; Zhao, L.; Wang, M.; Gu, J.; Wei, W.; Li, Q.; Ma, M.; Mu, Z.; Miao, Y. Guardians’ willingness to vaccinate their teenagers against COVID-19 in China: A national cross-sectional survey. J. Affect. Disord. 2021, 299, 196–204. [Google Scholar] [CrossRef]
- Ma, L.; Yang, J.; Zhang, T.; Han, X.; Huang, Q.; Yang, Y.; Feng, L.; Yang, W.; Wang, C. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: A cross-sectional study on the guardians of children in China. Hum. Vaccines Immunother. 2022, 18, 2049169. [Google Scholar] [CrossRef]
- Li, T.; Qiu, X.; Gong, X.; Zhan, R.; Zheng, X. The cross-sectional survey on COVID-19 vaccine hesitancy and it predictors among Chinese parents of 3–17 years aged children in Shenzhen City. Ann. Agric. Environ. Med. 2022, 29, 120–125. [Google Scholar] [CrossRef]
- Qin, C.; Wang, R.; Tao, L.; Liu, M.; Liu, J. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China. Front. Public Health 2022, 10, 834572. [Google Scholar] [CrossRef]
- Zhou, X.; Wang, S.; Zhang, K.; Chen, S.; Chan, P.S.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; et al. Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys. Vaccines 2022, 10, 1478. [Google Scholar] [CrossRef]
- Valente, T.W.; Fosados, R. Diffusion of Innovations and Network Segmentation: The Part Played by People in Promoting Health. Sex. Transm. Dis. 2006, 33, S23–S31. [Google Scholar] [CrossRef]
- Zhang, K.; Fang, Y.; Chan, P.S.-F.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; Zhou, X.; Wang, Z. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers. Int. J. Environ. Res. Public Health 2022, 19, 5245. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.C.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; Zhou, X.; Wang, Z. Behavioral Intention to Receive a COVID-19 Vaccination Among Chinese Factory Workers: Cross-sectional Online Survey. J. Med. Internet Res. 2021, 23, e24673. [Google Scholar] [CrossRef] [PubMed]
- District, L. Commerce Bureau of Shenzhen Municipality. 2022. Available online: http://commerce.sz.gov.cn/tzly/qyfb/gqcyjs/content/post_8571905.html (accessed on 25 November 2022).
- Pan, Y.; Fang, Y.; Xin, M.; Dong, W.; Zhou, L.; Hou, Q.; Li, F.; Sun, G.; Zheng, Z.; Yuan, J.; et al. Self-Reported Compliance with Personal Preventive Measures Among Chinese Factory Workers at the Beginning of Work Resumption Following the COVID-19 Outbreak: Cross-Sectional Survey Study. J. Med. Internet Res. 2020, 22, e22457. [Google Scholar] [CrossRef] [PubMed]
- Yuan, J.; Cao, B.; Zhang, C.; Chan, P.S.F.; Xin, M.; Fang, Y.; Chen, Y.; Huang, D.; Li, L.; Xuan, X.; et al. Changes in Compliance with Personal Preventive Measures and Mental Health Status Among Chinese Factory Workers during the COVID-19 Pandemic: An Observational Prospective Cohort Study. Front. Public Health 2022, 10, 831456. [Google Scholar] [CrossRef] [PubMed]
- Pan, Y.; Xin, M.; Zhang, C.; Dong, W.; Fang, Y.; Wu, W.; Li, M.; Pang, J.; Zheng, Z.; Wang, Z.; et al. Associations of Mental Health and Personal Preventive Measure Compliance with Exposure to COVID-19 Information during Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study. J. Med. Internet Res. 2020, 22, e22596. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.C.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.Q.; Zhou, X.; Wang, Z. Parental acceptability of COVID-19 vaccination for children under the age of 18 years in China: Cross-sectional online survey. JMIR Pediatr. Parent. 2020, 3, e24827. [Google Scholar] [CrossRef]
- Wang, Z.; Wang, J.; Fang, Y.; Gross, D.L.; Wong, M.C.; Wong, E.L.; Lau, J.T. Parental acceptability of HPV vaccination for boys and girls aged 9–13 years in China—A population-based study. Vaccine 2018, 36, 2657–2665. [Google Scholar] [CrossRef]
- Coronavirus (COVID-19) Vaccinations. 2022. Available online: https://news.google.com/covid19/map?hl=zhCN&mid=%2Fm%2F0fbp0&gl=CN&ceid=CN%3Azh-Hans&state=4 (accessed on 3 December 2022).
- China Approves COVID-19 Vaccines for Children above 3 Years Old. Available online: https://www.globaltimes.cn/page/202106/1225639.shtml (accessed on 9 December 2022).
- Net, X. Over 84 Million Chinese Children Vaccinated against COVID-19. Available online: http://www.news.cn/english/2021-11/13/c_1310309137.htm (accessed on 10 December 2022).
- Katz, S.E.; Edwards, K. Protecting Children Against Omicron. JAMA 2022, 327, 2195–2197. [Google Scholar] [CrossRef]
- Buonsenso, D.; Valentini, P.; Macchi, M.; Folino, F.; Pensabene, C.; Patria, M.F.; Agostoni, C.; Castaldi, S.; Lecce, M.; Giannì, M.L.; et al. Caregivers’ Attitudes Toward COVID-19 Vaccination in Children and Adolescents with a History of SARS-CoV-2 Infection. Front. Pediatr. 2022, 10, 867968. [Google Scholar] [CrossRef]
Table 1.
Background characteristics of the parents.
| Round 1 (n = 208) | Round 2 (n = 229) | p Values | |
|---|---|---|---|
| n (%) | n (%) | ||
| Sociodemographic characteristics | |||
| Age of the parent, years | |||
| 18–30 | 106 (51.0) | 80 (34.9) | |
| 31–40 | 97 (46.6) | 124 (54.1) | |
| >40 | 5 (2.4) | 25 (10.9) | <0.001 |
| Sex | |||
| Male | 89 (42.8) | 98 (42.8) | |
| Female | 119 (57.2) | 131 (57.2) | 1.00 |
| Relationship status | |||
| Married | 203 (97.6) | 224 (97.8) | |
| Single or divorced | 3 (1.4) | 5 (2.2) | |
| Having a stable partner | 2 (1.0) | 0 (0.0) | 0.28 |
| Education | |||
| Senior high or below | 127 (61.1) | 113 (49.3) | |
| College and above | 81 (38.9) | 116 (50.7) | 0.02 |
| Monthly personal income, RMB (USD) | |||
| <3000 (462) | 49 (23.6) | 35 (15.3) | |
| 3000–6999 (462–1077) | 112 (53.8) | 139 (60.7) | |
| ≥7000 (1078) | 47 (22.6) | 55 (24.0) | 0.09 |
| Type of work | |||
| Frontline workers | 132 (63.5) | 160 (69.9) | |
| Management staff | 76 (36.5) | 69 (30.1) | 0.19 |
| Age of the child, months | |||
| 24–35 | 112 (53.8) | 119 (52.0) | |
| 12–23 | 91 (43.8) | 95 (41.5) | |
| 6–11 | 5 (2.4) | 15 (6.6) | 0.12 |
| Personal COVID-19 preventive measures in the past month | |||
| Frequency of face mask wearing in public spaces or on transportation other than the workplace | |||
| Every time | 155 (74.5) | 179 (78.2) | |
| Often | 34 (16.3) | 44 (19.2) | |
| Sometimes | 16 (7.7) | 5 (2.2) | |
| Never | 3 (1.4) | 1 (0.4) | 0.03 |
| Frequency of face mask wearing when you have close contact with other people in the workplace | |||
| Every time | 133 (63.9) | 167 (72.9) | |
| Often | 45 (21.6) | 49 (21.4) | |
| Sometimes | 25 (12.0) | 11 (4.8) | |
| Never | 5 (2.4) | 2 (0.9) | 0.02 |
| Frequency of sanitizing of hands, using soaps, liquid soaps, or alcohol-based sanitizer, after returning from public spaces or touching public installations | |||
| Every time | 110 (52.9) | 109 (47.6) | |
| Often | 53 (25.5) | 69 (30.1) | |
| Sometimes | 41 (19.7) | 44 (19.2) | |
| Never | 4 (1.9) | 7 (3.1) | 0.57 |
| Self-reported avoiding of social and meal gathering with other people who do not live together | |||
| No | 82 (39.4) | 93 (40.6) | |
| Yes | 126 (60.6) | 136 (59.4) | 0.88 |
| Self-reported avoiding of crowded places | |||
| No | 72 (34.6) | 81 (35.4) | |
| Yes | 136 (65.4) | 148 (64.6) | 0.95 |
Table 2.
Changes in parental acceptability and attitudes related to children’s COVID-19 vaccination.
Table 2.
Changes in parental acceptability and attitudes related to children’s COVID-19 vaccination.
| Round 1 (n = 208) | Round 2 (n = 229) | Unadjusted p Values | Adjusted p Values a | Effect Size | |
|---|---|---|---|---|---|
| n (%) | n (%) | ||||
| Parental acceptability of COVID-19 vaccination for their child aged 6–35 months | |||||
| Likelihood of having the child take up COVID-19 vaccination | |||||
| Very unlikely/unlikely/neutral | 69 (33.2) | 47 (20.5) | |||
| Likely/very likely | 139 (66.8) | 182 (79.5) | 0.004 | 0.01 | 0.29 |
| Parental hesitancy to receive COVID-19 vaccination | |||||
| No | 171 (82.2) | 228 (99.6) | |||
| Yes | 37 (17.8) | 1 (0.4) | <0.001 | <0.001 | 0.74 |
| Attitudes toward COVID-19 vaccination for their children | |||||
| Positive attitudes toward COVID-19 vaccination, n (%) agree | |||||
| COVID-19 vaccination is highly effective in protecting your child from COVID-19 | 119 (57.2) | 165 (72.1) | 0.002 | 0.02 | 0.31 |
| Taking up COVID-19 vaccination can contribute to the control of COVID-19 in China | 180 (86.5) | 214 (93.4) | 0.02 | 0.01 | 0.23 |
| China will have an adequate supply of COVID-19 vaccine | 161 (77.4) | 204 (89.1) | 0.002 | 0.001 | 0.32 |
| Positive Attitude Scale score, mean (SD) | 8.1 (1.1) | 8.5 (0.9) | <0.001 | 0.002 | 0.34 |
| Negative attitudes toward COVID-19 vaccination, n (%) agree | |||||
| Your child will have severe side effects after receiving COVID-19 vaccination | 27 (13.0) | 33 (14.4) | 0.77 | 0.89 | 0.04 |
| The protection of COVID-19 vaccines will only last for a short time | 45 (21.6) | 114 (49.8) | <0.001 | <0.001 | 0.60 |
| Your child is afraid of vaccination | 49 (23.6) | 55 (24.0) | 1.00 | 0.62 | 0.009 |
| You do not have time to take your child for COVID-19 vaccination | 33 (15.9) | 57 (24.9) | 0.03 | 0.04 | 0.22 |
| Negative Attitude Scale score, mean (SD) | 7.6 (1.6) | 7.9 (1.9) | 0.06 | 0.03 | 0.18 |
| Perceived subjective norm related to child’s COVID-19 vaccination: your family member would support you in having the child take up COVID-19 vaccination | |||||
| Agree, n (%) | 105 (50.5) | 156 (68.1) | <0.001 | <0.001 | 0.36 |
| Response score, mean (SD) | 2.4 (0.6) | 2.6 (0.6) | <0.001 | 0.004 | 0.33 |
| Perceived behavioural control to have the child take up COVID-19 vaccination: having the child receive COVID-19 vaccination is easy for you if you want them to | |||||
| Agree, n (%) | 99 (47.6) | 143 (62.4) | 0.003 | 0.02 | 0.30 |
| Response score, mean (SD) | 2.4 (0.6) | 2.6 (0.6) | 0.002 | 0.01 | 0.29 |
| Frequency of exposing to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | |||||
| Testimonials given by recipients of COVID-19 vaccination on social media | |||||
| Almost none | 100 (48.1) | 53 (23.1) | |||
| Seldom | 55 (26.4) | 72 (31.4) | |||
| Sometimes | 33 (15.9) | 69 (30.1) | |||
| Always | 20 (9.6) | 35 (15.3) | <0.001 | <0.001 | 0.34 |
| Response score, mean (SD) | 1.9 (1.0) | 2.4 (1.0) | <0.001 | <0.001 | 0.50 |
| COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | |||||
| Almost none | N.A. | 39 (17.0) | |||
| Seldom | N.A. | 79 (34.5) | |||
| Sometimes | N.A. | 66 (28.8) | |||
| Always | N.A. | 45 (19.7) | |||
| Response score, mean (SD) | N.A. | 2.5 (1.0) | N.A. | N.A. | N.A. |
| Infectiousness and harms of the variants concern of COVID-19 | |||||
| Almost none | N.A. | 26 (11.4) | |||
| Seldom | N.A. | 53 (23.1) | |||
| Sometimes | N.A. | 88 (38.4) | |||
| Always | N.A. | 62 (27.1) | |||
| Response score, mean (SD) | N.A. | 2.8 (1.0) | N.A. | N.A. | N.A. |
| Outbreak caused by variants concern of COVID-19 in some places of China | |||||
| Almost none | N.A. | 34 (14.8) | |||
| Seldom | N.A. | 71 (31.0) | |||
| Sometimes | N.A. | 82 (35.8) | |||
| Always | N.A. | 42 (18.3) | |||
| Response score, mean (SD) | N.A. | 2.6 (1.0) | N.A. | N.A. | N.A. |
| People contract COVID-19 after receiving primary series of COVID-19 | |||||
| Almost none | N.A. | 50 (21.8) | |||
| Seldom | N.A. | 93 (40.6) | |||
| Sometimes | N.A. | 71 (31.0) | |||
| Always | N.A. | 15 (6.6) | |||
| Response score, mean (SD) | N.A. | 2.2 (0.9) | N.A. | N.A. | N.A. |
a: Adjusted p values: adjusted for age of the parent, education level, frequency of face mask wearing in public spaces or on transportation other than the workplace, and frequency of face mask wearing when you have close contact with other people in the workplace.
Table 3.
Associations between background characteristics and parental acceptability of COVID-19 vaccination for their children aged 6–35 months.
Table 3.
Associations between background characteristics and parental acceptability of COVID-19 vaccination for their children aged 6–35 months.
| Round 1 (n = 208) | Round 2 (n = 229) | |||
|---|---|---|---|---|
| OR (95%CI) | p Values | OR (95%CI) | p Values | |
| Sociodemographic characteristics | ||||
| Age group, years | ||||
| 18–30 | 1.0 | 1.0 | ||
| 31–40 | 1.57 (0.87, 2.84) | 0.14 | 0.88 (0.45, 1.74) | 0.72 |
| >40 | 0.91 (0.15, 5.68) | 0.92 | 6.48 (0.82, 51.37) | 0.08 |
| Sex | ||||
| Male | 1.0 | 1.0 | ||
| Female | 1.14 (0.64, 2.04) | 0.66 | 2.64 (1.36, 5.11) | 0.004 |
| Relationship status | ||||
| Married | 1.0 | 1.0 | ||
| Single or divorced | N.A. | N.A. | 1.03 (0.11, 9.47) | 0.98 |
| Having a stable partner | 0.50 (0.03, 8.18) | 0.63 | N.A. | N.A. |
| Education | ||||
| Senior high or below | 1.0 | 1.0 | ||
| College and above | 0.90 (0.50, 1.63) | 0.73 | 0.36 (0.18, 0.71) | 0.003 |
| Monthly personal income, RMB (USD) | ||||
| <3000 (462) | 1.0 | 1.0 | ||
| 3000–6999 (462–1077) | 1.17 (0.57, 2.38) | 0.67 | 0.54 (0.17, 1.65) | 0.28 |
| ≥7000 (1078) | 0.94 (0.41, 2.16) | 0.88 | 0.32 (0.10, 1.04) | 0.06 |
| Type of work | ||||
| Frontline workers | 1.0 | 1.0 | ||
| Management staff | 0.77 (0.43, 1.40) | 0.39 | 0.63 (0.32, 1.23) | 0.17 |
| Age of the child, months | ||||
| 24–35 | 1.0 | 1.0 | ||
| 12–23 | 1.00 (0.56, 1.81) | 0.99 | 1.00 (0.62, 1.93) | 0.99 |
| 6–11 | 0.74 (0.12, 4.62) | 0.75 | 1.73 (0.37, 8.18) | 0.49 |
| Personal COVID-19 preventive measures in the past month | ||||
| Frequency of face mask wearing in public spaces or on transportation other than the workplace | ||||
| Never/sometimes/often | 1.0 | 1.0 | ||
| Every time | 1.82 (0.96, 3.46) | 0.07 | 1.50 (0.72, 3.12) | 0.28 |
| Frequency of face mask wearing when you have close contact with other people in the workplace | ||||
| Never/sometimes/often | 1.0 | 1.0 | ||
| Every time | 1.01 (0.56, 1.84) | 0.97 | 3.12 (1.60, 6.12) | 0.001 |
| Frequency of sanitizing of hands, using soaps, liquid soaps, or alcohol-based sanitizer, after returning from public spaces or touching public installations | ||||
| Never/sometimes/often | 1.0 | 1.0 | ||
| Every time | 1.04 (0.59, 1.86) | 0.89 | 2.92 (1.45, 5.89) | 0.003 |
| Self-reported avoiding of social and meal gathering with other people who do not live together | ||||
| No | 1.0 | 1.0 | ||
| Yes | 2.21 (1.22, 3.98) | 0.01 | 0.99 (0.52, 1.90) | 0.98 |
| Self-reported avoiding of crowed places | ||||
| No | 1.0 | 1.0 | ||
| Yes | 2.14 (1.18, 3.90) | 0.01 | 0.82 (0.42, 1.63) | 0.58 |
OR: crude odds ratios. N.A.: not applicable.
Table 4.
Factors associated with parental acceptability of COVID-19 vaccination for their children aged 6–35 months.
Table 4.
Factors associated with parental acceptability of COVID-19 vaccination for their children aged 6–35 months.
| Round 1 (n = 208) | Round 2 (n = 229) | |||||||
|---|---|---|---|---|---|---|---|---|
| OR (95%CI) | p Values | AOR (95%CI) | p Values | OR (95%CI) | p Values | AOR (95%CI) | p Values | |
| Parental hesitancy to receive COVID-19 vaccination | ||||||||
| No | 1.0 | 1.0 | ||||||
| Yes | 0.26 (0.18, 0.38) | <0.001 | 0.25 (0.12, 0.54) | <0.001 | N.A. | N.A.. | N.A. | N.A. |
| Attitudes toward COVID-19 vaccination for their children | ||||||||
| Positive Attitude Scale | 1.88 (1.41, 2.50) | <0.001 | 1.86 (1.38, 2.50) | <0.001 | 2.04 (1.47, 2.85) | <0.001 | 1.99 (1.40, 2.85) | <0.001 |
| Negative Attitude Scale | 0.96 (0.80, 1.14) | 0.61 | 0.96 (0.80, 1.16) | 0.69 | 0.86 (0.72, 1.01) | 0.07 | 0.80 (0.66, 0.97) | 0.02 |
| Perceived subjective norm | 4.68 (2.66, 8.23) | <0.001 | 4.69 (2.64, 8.32) | <0.001 | 8.07 (4.20, 15.48) | <0.001 | 8.33 (4.12, 16.83) | <0.001 |
| Perceived behavioural control | 1.91 (1.21, 2.99) | 0.005 | 2.02 (1.27, 3.21) | 0.003 | 2.90 (1.73, 4.87) | <0.001 | 3.09 (1.76, 5.43) | <0.001 |
| Frequency of exposing to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||||||||
| Testimonials given by recipients of COVID-19 vaccination on social media | 1.22 (0.91, 1.65) | 0.19 | 1.24 (0.91, 1.68) | 0.18 | 0.96 (0.70, 1.33) | 0.83 | 0.79 (0.55, 1.13) | 0.20 |
| COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | N.A. | N.A. | N.A. | N.A. | 0.85 (0.61, 1.18) | 0.32 | 0.82 (0.57, 1.17) | 0.27 |
| Infectiousness and harms of the variants concern of COVID-19 | N.A. | N.A. | N.A. | N.A. | 0.87 (0.62, 1.22) | 0.41 | 0.78 (0.53, 1.14) | 0.20 |
| Outbreak caused by variants concern of COVID-19 in some places of China | N.A. | N.A. | N.A. | N.A. | 0.77 (0.54, 1.08) | 0.13 | 0.80 (0.55, 1.17) | 0.25 |
| People contract COVID-19 after receiving primary series of COVID-19 | N.A. | N.A. | N.A. | N.A. | 0.88 (0.61, 1.28) | 0.50 | 0.92 (0.62, 1.38) | 0.69 |
OR: crude odds ratios. AOR: adjusted odds ratios, odds ratios adjusted for significant background characteristics in Table 3. N.A.: not applicable.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Zhang, K.; Liang, X.; Tam, K.L.W.; Kawuki, J.; Chan, P.S.-f.; Chen, S.; Fang, Y.; Cao, H.; Zhou, X.; Chen, Y.; et al. Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021. Vaccines 2023, 11, 170. https://doi.org/10.3390/vaccines11010170
AMA Style
Zhang K, Liang X, Tam KLW, Kawuki J, Chan PS-f, Chen S, Fang Y, Cao H, Zhou X, Chen Y, et al. Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021. Vaccines. 2023; 11(1):170. https://doi.org/10.3390/vaccines11010170
Chicago/Turabian StyleZhang, Kechun, Xue Liang, Karen Lau Wa Tam, Joseph Kawuki, Paul Shing-fong Chan, Siyu Chen, Yuan Fang, He Cao, Xiaofeng Zhou, Yaqi Chen, and et al. 2023. "Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021" Vaccines 11, no. 1: 170. https://doi.org/10.3390/vaccines11010170
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
